YASMIN ALARAN: Open Payments
NPI 1962045922 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,694 in 50 payments from 16 companies in 2025. Trend: 2023 $821 · 2024 $806 · 2025 $1,694
Food & beverage: $1,491Education: $203
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $359 |
| Dendreon Pharmaceuticals LLC | 7 | $252 |
| ACCORD HEALTHCARE, INC. | 3 | $175 |
| Sumitomo Pharma America, Inc. | 5 | $135 |
| ABBVIE INC. | 5 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Astellas Pharma US Inc | 2 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $84 |
| UROGEN PHARMA, INC. | 2 | $79 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $72 |
Products named: PROVENGE, ERLEADA, Camcevi, RYBREVANT, GEMTESA, LUPRON DEPOT, Nubeqa, YONSA.
Industry payments across CA — which companies pay providers there.
